Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals Upstate Unit Inks Four Drug-Screening Agreements

NEW YORK, Feb. 17 (GenomeWeb News) - Serologicals' Upstate Group yesterday said it has signed agreements to provide drug-screening services to Array Biopharma and three pharmaceutical companies.


The drug makers will use Upstate's KinaseProfiler service to help them determine the selectivity and specificity of candidate compounds, the company said.


The names of three drug makers or financial details of the transactions were not disclosed.

Upstate is a wholly owned subsidiary of Serologicals, which acquired the firm in a $205 million cash-and-stock purchase in September 2004.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.